Bouche, Gauthier
Anticancer Fund
4 papers on CoChatORCID 0000-0002-3407-2788
Most cited papers
- Verified
A phase Ib/IIa trial of 9 repurposed drugs combined with temozolomide for the treatment of recurrent glioblastoma: CUSP9v3
Halatsch, M.-E., Kast, R. E., Karpel-Massler, G., Mayer, B., Zolk, O., Schmitz, B., Scheuerle, A., Maier, L., Bullinger, L., Mayer-Steinacker, R., et al. (2021) · Neuro-Oncology Advances
Glioma Diagnosis and TreatmentPARP inhibition in cancer therapy
Cited by 74
- Verified
Repurposing drugs in oncology: From candidate selection to clinical adoption
Pantziarka, P., Verbaanderd, C., Huys, I., Bouche, G., & Meheus, L. (2021) · Seminars in Cancer Biology
Pharmaceutical Economics and PolicyPharmaceutical studies and practices
Cited by 69
- Verified
Use of non-cancer drugs and survival among patients with pancreatic adenocarcinoma: a nationwide registry-based study in Norway
Støer, N. C., Bouche, G., Pantziarka, P., Sloan, E. K., Andreassen, B. K., & Botteri, E. (2021) · Acta Oncologica
Pancreatic and Hepatic Oncology ResearchCancer, Lipids, and Metabolism
Cited by 22
- Verified
Pancreatic resection with perioperative drug repurposing of propranolol and etodolac: trial protocol of the phase-II randomised placebo controlled PROSPER trial
Hüttner, F. J., Rooman, I., Bouche, G., Knebel, P., Hüsing, J., Mihaljevic, A. L., Hackert, T., Strobel, O., Büchler, M. W., & Diener, M. K. (2020) · BMJ Open
Cancer, Stress, Anesthesia, and Immune ResponsePancreatic and Hepatic Oncology Research
Cited by 13
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free